CD4 and lymphangioleiomyomatosis: While we saw an overall reduction in CD4+ and CD8+ T cell numbers with CpG-ODN treatment in LAM lungs (Fig E6), we found a shift in the activation and skewing of both CD8+ and CD4+ T cells in the lungs.